Home/Filings/4/0001062993-24-001435
4//SEC Filing

Shantharam Harish 4

Accession 0001062993-24-001435

CIK 0001042074other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:33 PM ET

Size

7.0 KB

Accession

0001062993-24-001435

Insider Transaction Report

Form 4
Period: 2024-01-24
Shantharam Harish
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-01-24+74,75074,750 total
    Exercise: $22.85Exp: 2034-01-23Common Stock (74,750 underlying)
  • Award

    Common Stock

    2024-01-24+20,12520,125 total
Footnotes (2)
  • [F1]The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
  • [F2]The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001976391

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:33 PM ET
Size
7.0 KB